A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers. by Cowan, FM et al.
Ferrand, R; Lowe, S; Whande, B; Munaiwa, L; Langhaug, L; Cowan,
F; Mugurungi, O; Gibb, D; Munyati, S; Williams, BG; Corbett, EL
(2010) Survey of children accessing HIV services in a high prevalence
setting: time for adolescents to count? Bulletin of the World Health
Organization, 88 (6). pp. 428-34. ISSN 0042-9686
Downloaded from: http://researchonline.lshtm.ac.uk/3461/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution Non-commercial No Derivatives
http://creativecommons.org/licenses/by-nc-nd/2.5/
428
Research
Bull World Health Organ 2010;88:428–434 | doi:10.2471/BLT.09.066126
Introduction
Infection with human immunodeficiency virus (HIV) is the 
leading cause of death in southern Africa, which has the highest 
prevalence of HIV infection in the world.1 Without interven-
tions, the risk of mother-to-child transmission (MTCT) of 
HIV is common;2 thus, the adult HIV epidemic in the region 
has been followed by an epidemic of vertically-acquired HIV 
infection among children.1 The health-care needs of children 
are poorly served in most low-income countries,3–5 and adults 
have been the main targets of HIV-care programmes. However, 
there is growing recognition of the need for equitable access to 
antiretroviral therapy (ART) for HIV-infected children as well.
As HIV epidemics in Africa mature, the age profile of 
children in need of HIV care is changing. The infection ap-
pears to progress slowly in one-quarter to one-third of HIV-
infected infants. These “slow progressors” may have a median 
life-expectancy as high as 14–16 years, even without ART.6,7 In 
countries with severe epidemics of early-onset HIV infection, 
more and more cases are presenting with clinical symptoms in 
late childhood or adolescence.8,9 Furthermore, as access to ART 
and provision of HIV care improve, a greater proportion of HIV-
infected infants is likely to survive to adolescence.10
Despite the growing numbers of older children and ado-
lescents who develop symptoms, there has been little focus on 
providing this group with specialized HIV care.11 In industrial-
ized countries, adolescent medicine is a distinct clinical special-
ity. However, in resource-poor settings, dedicated health-care 
services for adolescents are few, and children generally move from 
paediatric to adult care services at 8–12 years of age.
Zimbabwe has experienced a severe and early-onset HIV 
epidemic, with the prevalence of HIV infection in adults peak-
ing at 30% in 1997 and subsequently declining to below 15% by 
2007. In 2007, an estimated 120 000 children were living with 
HIV1 and 3.4% of children aged 10 years were HIV-infected 
long-term survivors following MTCT.12 Within a few years, 
HIV-related deaths among adolescent long-term survivors are 
likely to outnumber those among infants.12 However, as is typical 
for the region, HIV-care programmes routinely report data for 
only three age categories: 0–4, 5–14 and 15–49 years. Thus, there 
is no clear age profile of the older children receiving HIV care.
We investigated the number of children receiving HIV 
care in Zimbabwe to establish the proportion of adolescents 
(10–19 years of age). We also ascertained clinic staff perceptions 
of the main problems faced by HIV-infected younger children 
and adolescents.
Methods
Setting
Zimbabwe is divided into eight provinces and has two major 
cities – Harare and Bulawayo. ART first became available in 
the public health sector in 2004 and is now accessible through 
both primary care and hospital-based HIV services. The therapy 
is initiated in hospital HIV services, with continuing care de-
centralized, where possible, to the local primary care level. All 
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Objective To establish the proportion of adolescents among children infected with human immunodeficiency virus (HIV) in Zimbabwe who 
receive HIV care and support, and what clinic staff perceives to be the main problems faced by HIV-infected children and adolescents.
Methods In July 2008, we sent a questionnaire to all 131 facilities providing HIV care in Zimbabwe. In it we requested an age breakdown 
of the children (aged 0–19 years) registered for care and asked what were the two major problems faced by younger children (0–5 years) 
and adolescents (10–19 years).
Findings Nationally, 115 (88%) facilities responded. In 98 (75%) that provided complete data, 196 032 patients were registered and 
24 958 (13%) of them were children. Of children under HIV care, 33% were aged 0–4 years; 25%, 5–9 years; 25%, 10–14 years; 
and 17%, 15–19 years. Staff highlighted differences in the problems most commonly faced by younger children and adolescents. For 
younger children, such problems were malnutrition and lack of appropriate drugs (cited by 46% and 40% of clinics, respectively); for 
adolescents they concerned psychosocial issues and poor drug adherence (cited by 56% and 36%, respectively).
Conclusion Interventions for the large cohort of adolescents who are receiving HIV care in Zimbabwe need to target the psychosocial 
concerns and poor drug adherence reported by staff as being the main concerns in this age group.
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clinics providing HIV care are registered 
with Zimbabwe’s Ministry of Health and 
Child Welfare and issue a quarterly report 
of the number of patients registered on 
ART.
Facility engagement
The Ministry of Health and Child 
Welfare provided a list of all health-care 
facilities offering HIV treatment. Permis-
sion to conduct a survey was obtained 
from the Ministry of Health and Child 
Welfare and from the medical director 
of each province. No ethical approval 
was required because the data gathered 
did not report on individual patients and 
were considered to be an audit of HIV 
clinical services.
Each patient who registers at an 
HIV care service is serially recorded in 
numbered paper registers. The sex, age 
and date of registration are recorded at the 
time of enrolment, and a record of every 
clinic attendance or death is maintained 
in the register. Infants exposed to HIV but 
not diagnosed with HIV infection are not 
recorded on clinic registers.
In July 2008, we sent each facility a 
questionnaire requesting a breakdown of 
the number of registered children into 
four age groups (0–4 years, 5–9 years, 
10–14 years and 15–19 years) and the 
main modes of HIV testing of patients 
registered at the clinics. We requested 
the age at enrolment and the number 
of patients under active care rather than 
the number who had ever registered. We 
did not ask for the number of patients 
receiving ART.
To determine facility staff ’s view 
of the main problems encountered by 
children and by adolescents, we asked 
an open-ended question: “Name two 
challenges you encounter specifically in 
relation to looking after young children 
(aged 0–5 years) and/or adolescents 
(aged 10–19 years) infected with HIV in 
your clinic.” We also asked respondents to 
describe these problems in the context of 
the local environment.
We sent questionnaires by fax, e-mail, 
post or personal delivery to all health-care 
facilities identified with a return deadline 
of November 2008. Facilities had a finan-
cial incentive to complete the question-
naires accurately, and we contacted all 
those that did not return the question-
naire by the due date to clarify the reason 
for the lack of response. As a check on the 
accuracy of the data reported, we visited 
24 facilities. Their staff was advised of the 
visit in advance.
Data analysis
We entered the data into EPI-Info ver-
sion 3.4 (Centers for Disease Control 
and Prevention, Atlanta, United States 
of America) and analysed it using STATA 
version 10.0 (StataCorp., College Station, 
USA). We coded and analysed qualita-
tive data using principles of grounded 
theory.13 Responses to the open-ended 
question were coded to analyse emerg-
ing themes, with statements that cited 
multiple challenges coded into each ap-
plicable category. This meant that any one 
response could be coded into as many as 
four separate categories. If a respondent’s 
answer fell into a single category, it was 
counted only once.
Results
Characteristics of facilities and 
respondents
A total of 131 HIV-care facilities were 
identified. Of these, 115 (88%) re-
sponded to the questionnaire (Fig. 1). 
They comprised 65 (56%) clinics attached 
to hospitals, 48 (42%) clinics located 
within primary care facilities and 2 (2%) 
freestanding HIV-care clinics. In terms 
of funding, 78 (68%) were government 
clinics (11 run jointly with city mu-
nicipal health services), 18 (16%) were 
municipal city health clinics, 7 (6%) were 
funded by nongovernmental organiza-
tions, 6 (5%) were privately funded, and 
6 (5%) were funded through faith-based 
organizations. The main respondents were 
nurses-in-charge or clinic matrons (68%), 
followed by district medical officers or 
medical superintendents (17%), HIV 
programme managers or coordinators 
(13%) and counsellors (2%).
Clinics providing a partial 
response or none
The lowest response rates were from the 
western part of the country (Matabele-
land North and South provinces). Rea-
sons for non-response were non-receipt 
of questionnaires by the designated clinic 
respondent (6 clinics), or inability to re-
turn completed forms because of logistical 
problems with communication and postal 
services (10 clinics). Of the 115 clinics 
that provided responses, 17 were unable 
to provide an age breakdown for children 
registered in their care. These were fairly 
equally distributed through all provinces 
Fig. 1. Distribution of HIV clinics and response rates by province or city in Zimbabwe, 
2008
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and comprising 12% (26 166) of all pa-
tients in HIV care. Of these 17 clinics, 
9 provided no numbers of registered 
patients aged 15–19 years, and 8 provided 
no numbers of registered patients aged 
5–14 years.
Children in HIV-care services
Of the 115 HIV clinics that responded, 
98 (75%) provided the requested data 
as numbers of registered children in the 
four specified age-groups. These 98 clin-
ics recorded a total of 196 032 registered 
patients, not all of whom were on ART. 
Of these patients, 24 958 (13%) were 
children aged 0–19 years, and this group 
could be further broken down to 8370 
(33%) 0–4 years, 6130 (25%) 5–9 years, 
6334 (25%) 10–14 years and 4124 (17%) 
15–19 years.
Adult HIV prevalence differed 
little between provinces; however, the 
age profile of patients in care did vary 
more (Fig. 2). Bulawayo had the highest 
(21%) and Mashonaland Central the 
lowest (4%) proportion of children aged 
0–19 years among all patients (P < 0.001). 
Bulawayo also had the highest per cap-
ita load of adolescent patients (300 per 
100 000 population), with 2.8– 8.2 times 
more adolescents per capita than the other 
provinces.
Modes of HIV testing
Most (55%) respondents reported that 
children mainly accessed HIV testing in 
hospital after presenting with an illness. 
The remainder cited HIV clinics (28%), 
freestanding services (10%) or private 
doctors (1%) as routes through which 
children had accessed HIV testing; only 
6% of respondents mentioned primary 
care services. HIV clinics based in primary 
care facilities were more likely to have 
patients who had been tested through 
freestanding testing services or at primary 
care clinics than HIV clinics based in hos-
pitals (29% versus 6%, P < 0.008). At the 
clinic level, diagnosis was often delayed 
by lack of suitable diagnostic tests and the 
need for guardian consent before testing.
Problems faced by children and 
adolescents
Respondents identified major differences 
in the problems faced by young children 
and by adolescents (Table 1). Among 
young children, the most common prob-
lems were malnutrition (cited by 46% of 
clinics); unavailability of drugs, including 
paediatric formulations (40%); and in-
consistent caregiving (37%), which led to 
erratic clinic attendance. For adolescents, 
the most common issues were psychoso-
cial problems (56%), including lack of 
resources to seek help for these issues; 
erratic drug taking (36%); and lack of 
disclosure of HIV status (21%). Respon-
dents described the main psychosocial 
stressors for adolescents as stigma, diffi-
culty in identifying with HIV-negative 
peers, anxiety about sexual relationships 
and future planning, and low self-esteem 
and feelings of hopelessness. These stress-
ors were compounded by having to care 
for ill relatives and siblings and by being 
the head of the family.
Some problems were common to 
both age groups: inability to afford trans-
port fares and food and resulting inability 
to attend clinic appointments; malnutri-
tion; and cessation of treatment to avoid 
the increased hunger that results from 
taking ART. Erratic drug taking was an-
other problem for both age groups, but in 
younger children this was as a direct result 
of caregivers not bringing the children to 
the clinic or not consistently giving them 
medicines, whereas in adolescents it was 
mainly related to poor adherence to drug 
regimens. Respondents cited several issues 
that contributed to poor adherence in 
adolescents, including delayed disclosure 
of HIV status, a desire to conform, and 
attendance at boarding school, where it 
was not possible to supervise the taking 
of medicines from guardians.
Discussion
In Zimbabwe in 2008, over 10 000 adoles-
cents (10–19 years of age) were registered 
in HIV-care services. The adolescents 
comprised 42% of patients < 20 years of 
age, and outnumbered those < 5 years of 
age. To our knowledge, this is the first na-
tional report of the burden of adolescents 
in HIV-care services and of the problems 
faced by this age group in a high HIV 
prevalence setting. We achieved a high 
response rate and captured data from both 
hospitals and primary care clinics; hence, 
our results are likely to be reasonably rep-
resentative of the situation in Zimbabwe.
There has been considerable empha-
sis on the prevention of HIV infection 
in adolescents, but much less on the care 
of those already infected. Africa has an 
emerging epidemic of adolescent survi-
vors of HIV infection acquired by MTCT 
in the 1990s.12 Increasing numbers of 
long-term survivors are presenting for care 
for the first time during adolescence.8,14 
For example, in Harare, underlying HIV/
AIDS [acquired immunodeficiency syn-
drome] is now the most common reason 
for hospitalization in adolescence.14 
There is a 46% prevalence of HIV-related 
emergency admissions in the age group 
15–19 years, and investigations support 
vertical transmission as the most likely 
mode of infection in most cases.
In contrast to the well described 
infant AIDS epidemic, adolescent AIDS 
has only recently become clinically ap-
parent because of the delay between 
Fig. 2. Numbers of HIV-infected children, per 100 000 population, registered in HIV 
clinics by age group and province, Zimbabwe, 2008
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being infected in infancy and becoming 
symptomatic in adolescence. Thus, there 
is relatively little experience in HIV care 
for this age group. As HIV epidemics ma-
ture and prevention of MTCT becomes 
more widely available and successful, 
the numbers of HIV-infected infants 
entering HIV care will decline, while 
the numbers of already infected children 
surviving to older ages will continue to 
increase. Falling prevalence in adults will 
compound this trend. Thus, our survey 
findings may presage a regional trend 
towards increasing median age of children 
in HIV-care programmes.12 This trend 
will also be accelerated by the increasing 
availability of ART for infants and young 
children, which increases the probability 
of survival to adolescence, even for fast 
progressors.15 At present, however, any 
such regional trends are masked by the 
standard reporting of HIV data in just 
three age categories: 0–4, 5–14 and 
15–49 years. Accurate monitoring will 
require a breakdown of the categories to 
identify adolescents as a separate group.
We found substantial variation 
among provinces in the age profiles and 
per capita rates of adolescents receiving 
HIV care. This was a surprise because the 
adult HIV epidemic in Zimbabwe has 
been relatively homogenous, with little 
variability among geographical areas or 
between rural and urban zones.16,17 The 
variability among provinces reported 
here may be associated with differences in 
access to HIV-related diagnosis and care 
for adolescents. This would be consistent 
with our previous finding that delayed 
diagnosis, usually following multiple 
clinical symptoms of HIV infection over 
a prolonged period, is a major problem in 
this age group.8,14 Bulawayo, the second 
largest city in Zimbabwe, has a much 
greater per capita adolescent case load of 
HIV infection than any other administra-
tive area. Bulawayo showed early leader-
ship in establishing HIV diagnosis and 
care services in Zimbabwe and has run 
a dedicated adolescent HIV testing and 
care service since 2004. Matabeleland 
South and Mashonaland East have simi-
lar adult prevalence rates but report per 
capita rates that are less than one-eighth 
of those found in Bulawayo.18 If Bulawayo 
provides a better guide to the per capita 
rates of adolescents receiving HIV care 
than other administrative areas, then 
extrapolation of the city’s figures nation-
ally would imply that 34 000 adolescents 
need HIV care in Zimbabwe. We sepa-
rately estimated the burden of vertically-
acquired HIV infection in adolescents in 
Zimbabwe to be 43 357. This figure was 
based on a statistical model that took into 
account the timing and magnitude of the 
adult HIV epidemic and on assumptions 
about MTCT and the survival of infected 
infants.12,19 Thus, the true number of ado-
lescents with HIV infection may be much 
higher than the 10 000 currently known 
to HIV services.
For various reasons, barriers to HIV 
diagnosis and care are likely to be unusu-
ally large for adolescents. HIV testing of 
older children has not been emphasized 
because, until recently, long-term survival 
in the absence of treatment following 
MTCT was thought to be uncommon.20 
This means that HIV testing for young 
people in Zimbabwe can only be accessed 
in health-care facilities, with no freestand-
ing HIV-testing services for children less 
Table 1. Main problems, as reported by clinic staff, faced by HIV-infected young 
children and adolescents, Zimbabwe, 2008
Problems No. of clinics (%)
n  =  108 n  =  113
Young children 
(0–5 years)
Adolescents 
(10–19 years)
Psychosocial issues 6 (6) 63 (56)
Stigma 1 15
Denial (guardian/patient) 3 4
Schooling 0 12
Emotional and psychological 1 16
Guardian not coping 1 0
Puberty/future planning/peer pressure 0 11
Responsibility for siblings 0 5
Erratic drug taking 37 (34) 41 (36)
Poor attendance to clinic appointments 19 9
Poor adherence to collected medicines 18 32
Lack of resources (clinic level) 16 (15) 37 (33)
Paediatric clinical services 4 6
Trained staff 1 1
Space/material resources 3 5
Counselling 8 13
Psychosocial support services 0 12
Lack of disclosure of HIV status 4 (4) 24 (21)
Malnutrition 50 (46) 23 (20)
Orphanhood 23 (21) 17 (15)
Caregiver issues 40 (37) 17 (15)
Multiple/changing caregivers 11 4
Elderly caregiver 6 1
Ill parent/caregiver 4 0
Unsupportive/negligent caregiver 19 12
Economic difficulties 22 (20) 17 (15)
Transport fares 11 8
Money for food/medicines/school fees 11 9
Unavailability of drugs 43 (40) 13 (12)
Paediatric formulations 19 1
Drug shortages 24 12
Sexual health issues 1(1) 9 (8)
Unsafe sex/rape 1 7
Lack of sexual health services 0 2
Diagnosis of HIV infection 16 (15) 9 (8)
Lack of guardian consent 6 7
Lack of diagnostic tests 9 0
Lack of counselling and testing 1 2
Presentation with advanced disease 5 (5) 3 (3)
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صخلم
 له :سويرفلل عفترلما راشتنلاا تاذ نكاملأا في يشربلا يعانلما زوعلا سويرفب ةصاخ تامدخ لىع نولصحي نيذلا لافطلأا مييقتل حسم
؟ينقهارلماب مماتهلاا ءلايلإ تقولا ناح
 زوعلا  سويرف ىودعب  ينباصلما  لافطلأا  ينب  ينقهارلما  ةبسن  باسح ضرغلا
 امو ،سويرفلاب ينصاخلا معدلاو ةياعرلا نوقلتيو يوبابيمز في يشربلا يعانلما
 ينغلابلاو لافطلأا هجاوت ةيسيئر لكاشم نويكينيلكلإا نولماعلا هبرتعي يذلا
.ىودعلاب ينباصلما
 نم  ًاقفرم  131  لىإ  ًانايبتسا  نوثحابلا  لسرأ  ،2008  ويلوي/زوتم  في  ةقيرطلا
 في  يشربلا  يعانلما  زوعلا  سويرفب  ينباصملل  ةياعرلا  مدقت  يتلا  قفارلما
 )ةنس  0-19(  لافطلأا  رمع  ميسقت  نايبتسلاا  في  نوثحابلا  بلطو  .يوبابيمز
 نع  نوثحابلا  لأسو  ،ةياعرلا  تامدخ  لىع  نولصحيو  قفرلما  في  ينلجسلما
 ينتلكشم بركأو )تاونس 0-5 رمع في( لافطلأا راغص اههجاوي ينتلكشم بركأ
.)ةنس 10-19 رمع في( نوقهارلما اههجاوي
 ةبسنب(  ًاقفرم  115  نايبتسلال  باجتسا  ،ينطولا  ديعصلا  لىع  تادوجولما
 ًاضيرم 196032 نأ اهيف دجوو ،ةلماك تانايب )75%( ًاقفرم 98 مدق .)88%
 لافطلأا  نمو  لافطلأا  نم  اوناك  مهنم  )13%(  24958  نأو  ،ينلجسم  اوناك
 مهنم 33% ناك يشربلا يعانلما زوعلا سويرفب ةصاخلا ةياعرلا نوقلتي نيذلا
 25% و ؛تاونس 5-9 ةيرمعلا ةئفلا في 25% و ؛تاونس 0-4 ةيرمعلا ةئفلا في
 دقو  .ةنس15-19  ةيرمعلا  ةئفلا  في  17% و  ؛ةنس  10-14  ةيرمعلا  ةئفلا  في
 اههجاوي يتلا ًاعويش ثركلأا لكاشلما ينب تافلاتخلاا قفارلما في نولماعلا حضوأ
 ةيذغتلا ءوس لثم لكاشم نوهجاوي لافطلأا راغصف .ينقهارلماو لافطلأا راغص
 ؛)لياوتلا لىع ،تادايعلا نم 40% و 46% تدروأ ماك( ةئملالما ةيودلأا صقنو
 مهلاثتما ءوسو ةيعماتجلااو ةيسفنلا لكاشلما وه قلقلا يرثي ماف نوقهارلما امأ
.)لياوتلا لىع ،قفارلما نم 36% و 56% تدروأ ماك( ةيودلأا يقلتب
 ينقهارملل قاطنلا ةعساولا ةيبارتلأا تلاخادلما فدهتست نأ يغبني جاتنتسلاا
 تامماتهلاا  يشربلا  يعانلما  زوعلا  سويرفب  ةصاخ  ةياعر  نوقلتي  نيذلا
 في نولماعلا  هنع غلبأ  الم  ًاقفو ةيودلأل  لاثتملاا  ءوسو ةيعماتجلااو ةيسفنلا
.ةيرمعلا ةئفلا هذه تامماتها بسح تامدخلل ةمدقلما قفارلما
than 16 years of age. Legal barriers to 
testing young people further hinder this 
process, because testing people less than 
16 years of age requires consent from a 
legal guardian. High rates of orphanhood 
result in frequent movement of children 
between different extended family mem-
bers, with no clearly defined guardian-
ship.21–23 We found that most children 
were diagnosed following presentation 
with acute illness; only a minority ac-
cessed testing through primary care or 
freestanding HIV-testing services.
The primary focus of paediatric HIV-
care programmes has been on infants and 
young children, for whom management 
challenges are very different from those 
of HIV-infected adolescents. The major 
problems reported in this survey for 
younger children reflect the dependence 
of younger children on caregivers. The 
main issues reported for adolescents, 
however, reflect the physiological and 
psychological changes that occur dur-
ing the transition to adulthood.24–27 
These issues are likely to affect successful 
management and are in line with the 
experience in industrialized countries, 
where psychosocial concerns (e.g. mental 
health problems, low self-esteem, lack of 
social support and poor drug adherence) 
pose substantial challenges to the success-
ful clinical management of adolescent 
chronic illness.25,28–31
The lack of services focusing on the 
specific health needs of HIV-infected 
adolescents has implications for the 
individual and for public health. Poor 
adherents risk developing drug resistance 
and subsequent treatment failure. This 
has adverse health consequences for the 
individual (particularly in settings with 
limited access to second-line ART); it 
also carries a risk of HIV transmission. 
Failure to address emerging sexuality 
may further increase the risk of unsafe 
sexual behaviour. Delayed disclosure of 
HIV diagnosis to children, commonly 
reported by respondents in this survey, 
is likely to have an additional impact on 
both drug adherence and secondary HIV 
prevention.32,33
This study had some limitations. It 
did not capture the proportion of patients 
who were on ART at the time of the sur-
vey. Also, some respondents may not have 
reported data accurately and consistently, 
and some patients registered in the clinics 
may not have been under active follow-up. 
However, we tried to offset these limita-
tions by visiting 24 clinics to verify that re-
porting instructions were being followed. 
Another limitation is that the study did 
not capture infants who were exposed 
to HIV but had not yet undergone test-
ing; this may partly account for the low 
proportion of children in the age group 
0–4 years. In addition, factors other than 
access to HIV testing may contribute to 
the variability among provinces and thus 
may affect the burden of adolescents cur-
rently requiring care. Such factors include 
fecundity and the prevalence of maternal 
HIV infection and in the 1990s, the prob-
ability of survival to adolescence in those 
not receiving ART, and the effects on 
orphanhood and ill health of migration 
in and out of the country.
The large numbers of adolescents un-
der HIV care in Zimbabwe are consistent 
with a changing age profile of childhood 
AIDS in the context of a maturing HIV 
epidemic. Other countries with similar 
epidemics are likely to experience the 
same phenomenon as HIV epidemics 
mature and PMTCT becomes more 
widely available. Children’s health needs 
change markedly with age; thus, stan-
dard reporting of HIV data with more 
age bands would help to inform service 
planning for older HIV-infected children 
and adolescents. Given that the burden of 
older children under HIV care is likely to 
increase, there will be a growing need for 
targeted interventions to address adher-
ence and secondary prevention of HIV 
infection. Researchers and service provid-
ers should make a priority of developing 
and implementing effective strategies for 
such interventions. ■
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Objectif Déterminer la proportion d’adolescents parmi les enfants infectés 
par le virus de l’immunodéficience humaine (VIH) au Zimbabwe recevant 
des soins et un soutien en rapport avec le VIH et ce que le personnel des 
dispensaires perçoit comme les principaux problèmes rencontrés par les 
enfants et les adolescents infectés par ce virus.
Méthodes En juillet 2008, nous avons envoyé un questionnaire à 
l’ensemble des 131 établissements délivrant des soins liés au VIH au 
Zimbabwe. Il était demandé dans ce questionnaire de classer par âge 
les enfants (0–19 ans) enregistrés pour recevoir des soins et d’indiquer 
les deux principaux problèmes se posant pour les plus jeunes (0–5 ans) 
et pour les adolescents (10–19 ans).
Résultats A l’échelle du pays, 115 (88 %) établissements ont répondu. 
Dans 98 établissements (75 %) ayant fourni des données complètes, 
196 032 patients ont été enregistrés, dont 24 958 (13 %) enfants. 
Parmi les enfants soignés contre le VIH/sida, 33 % étaient âgés de 0 à 
4 ans, 25 % de 5 à 9 ans, 25 % de 10 à 14 ans et 17 % de 15 à 19 
ans. Le personnel a mis en lumière des différences entre les problèmes 
qui se posaient le plus fréquemment pour les jeunes enfants et pour 
les adolescents. Pour les plus jeunes, ces problèmes concernaient la 
malnutrition et le manque de médicaments adaptés (cités par 46 et 40 % 
des dispensaires respectivement) ; pour les adolescents, il s’agissait plutôt 
de problèmes psychosociaux et d’une mauvaise observance du traitement 
(cités par 56 et 36 % des dispensaires respectivement).
Conclusion Les interventions destinées à l’importante cohorte 
d’adolescents qui reçoit des soins liés au VIH au Zimbabwe doivent viser 
les difficultés psychosociales et les défauts d’observance du traitement 
rapportés par le personnel en tant que problèmes les plus préoccupants 
dans cette tranche d’âges.
Resumen
Encuesta sobre los niños que acceden a los servicios de VIH en un entorno de alta prevalencia: ¿deberíamos 
pensar más en los adolescentes?
Objetivo Determinar la proporción de adolescentes que reciben atención 
y apoyo contra el VIH entre los niños infectados por el virus de la 
inmunodeficiencia humana (VIH) en Zimbabwe, así como los principales 
problemas que, en opinión del personal de los dispensarios, afrontan los 
niños y adolescentes infectados por el virus.
Métodos En julio de 2008 enviamos un cuestionario a los 131 centros que 
atienden a pacientes con VIH en Zimbabwe. En él solicitamos un desglose 
por edades de los niños (de 0 a 19 años) registrados para recibir atención 
y preguntamos cuáles eran los dos problemas que más afectaban a los 
niños más pequeños (0–5 años) y a los adolescentes (10–19 años).
Resultados A nivel nacional, respondieron en total 115 centros (88%). En 
98 (75%) que proporcionaron datos completos, había registrados 196 032 
pacientes, 24 958 (13%) de los cuales eran niños. De los niños atendidos 
por ser seropositivos, el 33% tenían entre 0 y 4 años; el 25%, 5–9 años, 
otro 25%, 10–14 años; y el 17%, 15–19 años. El personal resaltó las 
diferencias entre los problemas más comunes sufridos por los niños más 
pequeños y los que afectaban a los adolescentes. Ente los primeros cabe 
destacar la malnutrición y la falta de medicamentos apropiados (citados 
por el 46% y el 40% de los dispensarios, respectivamente); y en el caso 
de los adolescentes, los problemas psicosociales y el escaso seguimiento 
de la medicación (citados por el 56% y el 36%, respectivamente).
Conclusión En las intervenciones aplicadas en la extensa cohorte de 
adolescentes que están recibiendo atención para el VIH en Zimbabwe se 
debería centrar la atención en los aspectos psicosociales y el cumplimiento 
del tratamiento, cuestiones identificadas por el personal como los 
principales motivos de preocupación en ese grupo de edad.
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